drugset / Trial / NCT02249130
Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without Tipranavir
NaSingle-groupOpen-labelTreatment
Summary
To investigate the safety of a standard triple therapy regimen of delavirdine (DLV), zidovudine (ZDV), and lamivudine (3TC) following 14 days of experimental treatment with regimens of tipranavir (TPV) with and without ritonavir (RTV)
Timeline
- Start
- 1999-03
- Primary completion
- 2000-04
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ritonavir | Other / unclassified | — | — |
| Subject | Tipranavir | Small molecule | — | — |
| Background | Delavirdine | Small molecule | — | — |
| Background | Lamivudine | Other / unclassified | — | — |
| Background | Stavudine | Other / unclassified | — | — |
| Background | Zidovudine | Small molecule | — | — |